$ELTX Balance Sheet | Understand Stock

$ELTX

$1.83 +$0.13 (7.65%) Close

$ELTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets
Cash and cash equivalents
Grants receivable
Restricted cash, current
Prepaid expenses and other current assets
Notes receivable
Total current assets

Property and equipment, net
Operating lease, right-of-use assets
Investments in related parties
Other assets
Restricted cash, noncurrent
Other long-term prepaid assets
Total assets

Liabilities and stockholders’ equity
Current liabilities
Accounts payable
Accrued expenses
Deferred research obligation
Operating lease liability, current
Financing obligation, current
Unvested option exercise liability, current
Warrant liability
Convertible promissory notes payable at fair value
Series C convertible preferred stock at amortized cost
Series C convertible preferred stock at fair value
Other short-term debt
Total current liabilities

Warrant liabilities
Operating lease liability, noncurrent
Financing obligation, noncurrent
Deferred revenue—noncurrent
Other liabilities, noncurrent
Unvested option exercise liability, noncurrent
Convertible note - related party
Related Party
Total convertible note - related party
Long-term debt, net
Total liabilities
Convertible preferred stock
Series A Preferred Stock
Series B Preferred Stock
Series C
Total convertible preferred stock
Stockholders' equity:
Preferred stock, $0.01 par value; 10,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.01 par value per share; 300,000,000 shares authorized; 21,916,024 shares and 17,814,762 shares issued at June 30, 2026 and December 31, 2025, respectively; 21,901,569 and 17,800,307 outstanding as of June 30, 2026 and December 31, 2025, respectively
Treasury stock, zero and 316,088 shares outstanding as of December 31, 2021 and 2020, respectively
Treasury stock, at cost, 14,455 shares outstanding
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders' equity

Total liabilities and stockholders' equity

Convertible preferred stock, shares issued (in shares)
Series A Preferred Stock
Series B Preferred Stock
Series C
Total convertible preferred stock, shares issued (in shares)

Convertible preferred stock, shares outstanding (in shares)
Series A Preferred Stock
Series B Preferred Stock
Series C
Total convertible preferred stock, shares outstanding (in shares)
Treasury stock, shares outstanding (in shares)

Comments